ICU Medical, Inc. (NASDAQ:ICUI) Shares Sold by Corient Private Wealth LLC

Corient Private Wealth LLC decreased its holdings in shares of ICU Medical, Inc. (NASDAQ:ICUI - Free Report) by 61.6% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 2,233 shares of the medical instruments supplier's stock after selling 3,578 shares during the period. Corient Private Wealth LLC's holdings in ICU Medical were worth $346,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in ICUI. Point72 Hong Kong Ltd purchased a new position in shares of ICU Medical in the 3rd quarter valued at about $72,000. Venturi Wealth Management LLC grew its position in ICU Medical by 64.0% during the fourth quarter. Venturi Wealth Management LLC now owns 528 shares of the medical instruments supplier's stock worth $82,000 after buying an additional 206 shares during the period. Smartleaf Asset Management LLC increased its holdings in ICU Medical by 166.8% in the fourth quarter. Smartleaf Asset Management LLC now owns 907 shares of the medical instruments supplier's stock valued at $140,000 after buying an additional 567 shares in the last quarter. Coldstream Capital Management Inc. acquired a new stake in shares of ICU Medical during the 3rd quarter valued at approximately $227,000. Finally, OLD National Bancorp IN boosted its stake in shares of ICU Medical by 22.0% during the 4th quarter. OLD National Bancorp IN now owns 1,462 shares of the medical instruments supplier's stock worth $227,000 after acquiring an additional 264 shares in the last quarter. Institutional investors and hedge funds own 96.10% of the company's stock.

ICU Medical Price Performance

Shares of ICU Medical stock traded up $1.19 during trading on Thursday, hitting $141.57. 549,553 shares of the company were exchanged, compared to its average volume of 264,438. The firm has a 50 day moving average price of $152.29 and a 200 day moving average price of $162.93. The stock has a market capitalization of $3.47 billion, a price-to-earnings ratio of -30.98 and a beta of 0.73. The company has a quick ratio of 1.03, a current ratio of 2.29 and a debt-to-equity ratio of 0.75. ICU Medical, Inc. has a fifty-two week low of $93.36 and a fifty-two week high of $196.26.

Remove Ads

Analysts Set New Price Targets

Several equities analysts recently weighed in on ICUI shares. Raymond James set a $97.00 price objective on ICU Medical in a research note on Wednesday, March 12th. StockNews.com lowered ICU Medical from a "buy" rating to a "hold" rating in a report on Thursday, March 27th. Finally, Jefferies Financial Group raised ICU Medical from a "hold" rating to a "buy" rating and set a $200.00 price target for the company in a research note on Wednesday, December 11th. Two analysts have rated the stock with a hold rating, two have assigned a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus target price of $168.67.

ICU Medical Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.